Evidence-Based Guidelines for Treating Androgenetic Alopecia in Men and Women

The document discusses androgenetic alopecia (AGA), the most common hair loss disorder affecting both men and women, with initial signs often appearing during puberty and progressing with age. It affects up to 80% of white men and 42% of women, significantly impacting quality of life. The European Dermatology Forum (EDF) initiated a project to develop evidence-based guidelines for AGA treatment. Through a systematic review and a consensus conference, the effectiveness of current treatments was evaluated, resulting in recommendations aimed at providing dermatologists with evidence-based tools for selecting effective and safe treatments for AGA patients.